HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 167 filers reported holding HALOZYME THERAPEUTICS INC in Q1 2016. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $403,000 | +32.6% | 26,000 | +67.7% | 0.07% | +231.8% |
| Q1 2018 | $304,000 | -65.7% | 15,500 | -77.3% | 0.02% | -26.7% |
| Q1 2017 | $886,000 | +14.0% | 68,400 | +6.4% | 0.03% | -86.0% |
| Q3 2016 | $777,000 | +447.2% | 64,300 | +328.7% | 0.21% | +250.8% |
| Q1 2016 | $142,000 | -35.7% | 15,000 | -8.9% | 0.06% | -1.6% |
| Q3 2015 | $221,000 | +87.3% | 16,472 | +35.0% | 0.06% | +59.0% |
| Q4 2014 | $118,000 | -13.9% | 12,200 | -12.2% | 0.04% | -39.1% |
| Q2 2014 | $137,000 | -63.0% | 13,900 | -58.5% | 0.06% | -8.6% |
| Q3 2013 | $370,000 | – | 33,500 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 7,048,282 | $126,799,000 | 27.23% |
| First Light Asset Management, LLC | 1,630,591 | $29,334,000 | 5.01% |
| SNYDER CAPITAL MANAGEMENT L P | 3,393,057 | $61,041,000 | 3.48% |
| Bellevue Group AG | 7,663,956 | $137,874,000 | 2.67% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 307,633 | $5,531,000 | 2.52% |
| Lombard Odier Asset Management (Switzerland) SA | 900,000 | $16,191,000 | 2.17% |
| Elk Creek Partners, LLC | 654,362 | $11,772,000 | 2.02% |
| DOHENY ASSET MANAGEMENT /CA | 127,110 | $2,254,000 | 1.79% |
| Granite Investment Partners, LLC | 1,277,438 | $22,981,000 | 1.49% |
| Amia Capital LLP | 69,409 | $1,249,000 | 1.11% |